共 82 条
[1]
Raghavan D(1997)Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer Eur J. Cancer 33 566-574
[2]
Koczwara B(2003)Multidrug resistance in prostate cancer Onkologie 26 175-181
[3]
Javle M(2001)The development of androgen-independent prostate cancer Nat. Rev. Cancer 1 34-45
[4]
Van Brussel JP(1993)Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer Cancer 71 1098-1109
[5]
Mickisch GH(2004)Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N. Engl. J. Med. 351 1502-1512
[6]
Feldman BJ(1983)Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer J. Urol. 129 1001-1006
[7]
Feldman D(1994)Complexes of metals other than platinum as antitumour agents Eur. J. Clin. Pharmacol. 47 1-16
[8]
Yagoda A(1998)Anti-proliferative activity and mechanism of action of titanocene dichloride Br. J. Cancer 77 2088-2097
[9]
Petrylak D(2000)Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer Onkologie 23 60-62
[10]
Tannock IF(2004)Functionalized Cyclopentadienyl Titanium Organometallic Compounds as New Antitumor Drugs Organomet. 23 288-292